Company news

Resonance Health Ltd news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Liver Fibrosis Device Webinar Presentation

October 27, 2026

Investor Presentation Liver Fibrosis Device & Capital Raise

October 26, 2026

$6.0 Million Placement Oversubscribed

October 26, 2026

Liver Fibrosis Device - EPoC Study Results

October 26, 2026

Trading Halt

October 22, 2026

Global Strategic Alliance & MSA with Image Analysis Group

September 16, 2026

FY26 Full Year Results & Investor Webinar

August 27, 2026

Liver Fibrosis Device Progress & FY26 Portfolio Webinar

June 8, 2026

Profit Guidance Upgrade

May 5, 2026

Receipt of R&D Tax Incentive Refund

March 16, 2026

Half Year Results Presentation

February 26, 2026

Half Year Results

February 26, 2026

Half Year Report & Accounts

February 26, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

January 29, 2026

AGM Presentation

November 13, 2025

Investor Strategy Day Presentation

October 13, 2025

FY25 Full Year Results & FY26 Guidance Investor Presentation

August 29, 2025

Appendix 4E & Full Year Statutory Accounts

August 29, 2025

TrialsWest Expands with New Clinical Trial Site

July 8, 2025

Half Yearly Report and Accounts

February 27, 2025

Non-deal Investor Roadshow Presentation

December 1, 2024

Resonance Contracted by Major Global Pharma

November 18, 2024

Trading Halt

November 17, 2024

Full Year Results Presentation

August 29, 2024

Full Year Results

August 29, 2024

Appendix 4E & Annual Report to Shareholders

August 29, 2024

TrialsWest Expansion - New Trial Site

August 8, 2024

Completion of TrialsWest Acquisition

May 31, 2024

Investor Presentation - TrialsWest Acquisition

April 2, 2024

Acquisition of TrialsWest Group

April 2, 2024

Pause in Trading

March 28, 2024

Collaboration with Micron, Inc.

March 27, 2024

Half Yearly Report Results Announcement

February 28, 2024

Notification of buy-back - RHT

November 24, 2023

Annual Report & Appendix 4E

August 29, 2023

Management Transition

June 22, 2023

MRI Fibrosis Provisional Patent Application Lodged

December 20, 2022

Investor Presentation

November 24, 2022

Resonance Health Contracted for Two New Clinical Trials

November 10, 2022

Preliminary Final Report

August 30, 2022

FerriScan Now Available on 3 Tesla (3T) MRI Machines

July 24, 2022

Quarterly Activities/Appendix 4C Cash Flow Report

May 1, 2022

Platform Integration & Partnership Agreement with CARPL.ai

April 4, 2022

US CPT Code Confirmation for LiverSmart

February 6, 2022

Resonance Health Enters China - Pharma Contract Signed

January 27, 2022

Resonance Health Contracted for Third Party Clinical Trial

January 24, 2022

US FDA Clearance for LiverSmart

December 29, 2021

ASO Project New Data

December 19, 2021

LiverSmart Submitted to FDA for US Regulatory Clearance

December 2, 2021

Investor Presentation - Positioning for Growth

November 25, 2021

Older news releases →

Decks

The 5 newest of 41 decks. Every deck is listed under its year.